These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 15992756)

  • 1. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
    Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
    Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
    Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Ozdemir H; Karacorlu M; Karacorlu S
    Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
    Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
    Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
    Negi AK; Vernon SA; Lim CS; Owen-Armstrong K
    Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
    Grenga P; Lupo S; Domanico D; Vingolo EM
    Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion.
    Karacorlu M; Ozdemir H; Karacorlu SA
    Retina; 2005; 25(7):856-60. PubMed ID: 16205564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
    Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
    Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.